logo

NEWSROOM

test
August 27, 2025
Uncategorized

test

Read More
SunRegen Healthcare AG was recognized by JLABS of J&J
August 8, 2025
Uncategorized

SunRegen Healthcare AG was recognized by JLABS of J&J

Read More
Innosuisse Innovation Project Grant 2019
August 8, 2025
Uncategorized

Innosuisse Innovation Project Grant 2019

Read More
BIO-Europe Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG
August 8, 2025
Uncategorized

BIO-Europe Copenhagen’s Startup Slam Winner 2018: SunRegen Healthcare AG

Read More
EC SME Instrument Phase 1 Grant
August 12, 2025
Uncategorized

EC SME Instrument Phase 1 Grant

Read More
SunRegen Closed Seed Round Financing
August 8, 2025
Uncategorized

SunRegen Closed Seed Round Financing

Read More
Swiss final of IMAGINE IF!
August 8, 2025
Uncategorized

Swiss final of IMAGINE IF!

Read More
Swiss CTI Approved Phase 3 CTI Coaching
August 8, 2025
Uncategorized

Swiss CTI Approved Phase 3 CTI Coaching

Read More
CTI Approved Innovation Grant
August 8, 2025
Uncategorized

CTI Approved Innovation Grant

Read More
SunRegen Selected for Phase I of BaseLaunch Accelerator
August 8, 2025
Uncategorized

SunRegen Selected for Phase I of BaseLaunch Accelerator

Read More
CTI Offered CTI Coaching Phase 2
August 8, 2025
Uncategorized

CTI Offered CTI Coaching Phase 2

Read More

Subscription

Please fill in the below form or send email directly to [email protected]

    Supported By:

    CTI Coaching Phase 2 SunRegen
    SunRegen EU SME Instrument Phase 1 Grant Certificate

    SunRegen Healthcare AG is a biopharmaceutical company to develop drugs for the unmet medical needs of Neurodegenerative diseases and ophthalmic diseases. 

    Quick Links
    Contacts Info

    +41 76 461 6688

    SunRegen Healthcare AG
    Business Parc Reinach
    Christoph Merian-Ring 11, 4153 Reinach Switzerland

    [email protected]

    View Location

    Copyright © 2025, SunRegen Healthcare AG